NCT07443137 2026-03-02CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)Stanford UniversityPhase 1 Not yet recruiting20 enrolled
NCT06014762 2026-02-27P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell MalignanciesPoseida Therapeutics, Inc.Phase 1 Recruiting120 enrolled